Conditions for Granting Compulsory License for Dependent Invention Use
https://doi.org/10.17803/1994-1471.2021.132.11.117-132
Abstract
The paper deals with the institution of compulsory licensing for dependent inventions. Currently, its most important application is in the pharmaceutical industry. In order to launch generic drugs that are dependent inventions pharmaceutical companies have to enter into licensing agreements with the developers of original drugs. The law enforcement practice that began in 2018 in the Russian Federation showed that paragraph 2 of Art. 1362 of the Civil Code of the Russian Federation, which establishes the conditions for granting a compulsory license for the use of a dependent invention, needs to be harmonized and supplemented in order to protect and regulate the balance of private and public interests. To solve this problem, the author analyses the wording of the corresponding legal norm found in international agreements, in particular in the TRIPS Agreement, and in the national legislation of different countries as well as the effectiveness of its application. Based on the results of the study, possible clarifications are given to the conditions for granting a compulsory license for the use of a dependent invention under paragraph 2 of Art. 1362 of the Civil Code of the Russian Federation.
About the Author
M. M. PuchininaRussian Federation
Maria M. Puchinina, Expert on Intellectual Property; Lecturer (Course on "Fundamentals of Patent Law"); Postgraduate Student
Berezhkovskaya nab., d. 30, korp. 1, Moscow, 123993
References
1. Bahtiozina A. T. Patentnye spory v rossijskih sudah: novye vyzovy i novye taktiki // Intellektual’nye prava: vyzovy 21-go veka : materialy Mezhdunarodnoj konferencii (14–16 noyabrya 2019 g.) / pod red. E. P. Gavrilova, S. V. Butenko. — Tomsk : Izdatel’skij dom Tomskogo gosudarstvennogo universiteta. — 2019. — S. 15–21.
2. Vorozhevich A. S. Pravovaya ohrana zavisimyh izobretenij // Patenty i licenzii. Intellektual’nye prava. — 2019. — № 3. — S. 21–31.
3. Vorozhevich A. S. Riski i vozmozhnye posledstviya ogranichenij patentnyh prav v farmsfere // Vestnik Universiteta imeni O.Е. Кутафafina (MGYuA). — 2017. — № 6. — S. 42–53.
4. Vorozhevich A. S. Usloviya prinuditel’nogo licenzirovaniya: mezhdunarodnyj i nacional’nyj aspekt // Vestnik Arbitrazhnogo suda Moskovskogo okruga. — 2015. — № 2. — S. 14–30.
5. Gavrilov E. P. Zavisimye izobreteniya i «stolknoveniya» patentnyh zayavok // Patenty i licenzii. Intellektual’nye prava. — 2008. — № 3. — S. 17–26.
6. Zav’yalova M. Prinuditel’noe licenzirovanie kak mekhanizm-isklyuchenie v farmacevticheskom sektore // Remedium. — 2016. — № 12. — S. 6–14.
7. Zalesov A. V. Osobennosti zashchity patentnyh prav v oblasti farmacevtiki v Rossii // Intellektual’nye prava: vyzovy 21-go veka : materialy Mezhdunarodnoj konferencii (14–16 noyabrya 2019 g.) / pod red. E. P. Gavrilova, S. V. Butenko. — Tomsk : Izdatel’skij dom Tomskogo gosudarstvennogo universiteta. — 2019. — S. 52–65.
8. Ivanov A. Yu. Prinuditel’noe licenzirovanie dlya innovacionnogo razvitiya: o neobhodimosti balansirovki rezhima intellektual’nyh prav // Zakon. — 2017. — № 5. — S. 78–93.
9. Karpova N. N. Intellektual’naya sobstvennost’ i VTO // Rossijskoe predprinimatel’stvo. — 2012. — T. 13. — № 2. — S. 16–26.
10. Kartavcova T. V., Andreeva D. M., Gil’deeva G. N. Rol’ FDA v processe registracii lekarstvennyh sredstv na territorii SShA // Farmaciya. — 2015. — № 3. — S. 53–56.
11. Kolesnikov D. S., Ugryumov V. M. Opasnye posledstviya prinuditel’nogo licenzirovaniya patentov v oblasti farmacevtiki // Patenty i licenzii. Intellektual’nye prava. — 2015. — № 9. — S. 39–51.
12. Puchinina M. M. Prinuditel’naya licenziya — balans chastnyh i obshchestvennyh interesov // Sbornik materialov II Mezhdunarodnoj konferencii molodyh uchenyh «Intellektual’naya sobstvennost’: vzglyad v budushchee» / Rossijskaya gosudarstvennaya akademiya intellektual’noj sobstvennosti, g. Moskva, 29 aprelya 2020 g. ; pod red. O. A. Flyaginoj. — M. : RGAIS. — 2020. — Ch. 2. — S. 46–53.
13. Sadykov R. M. Problemy pravovoj ohrany zavisimyh ob"ektov patentnyh prav // Patenty i licenzii. Intellektual’nye prava. — 2018. — № 5. — S. 48–52.
14. Farmacevticheskij rynok Rossii. Itogi 2015 // Annual report. DSM GROUP. — 2015. — 124 s.
15. Shchedrina N. D. Uchet publichnyh interesov v prinuditel’nom licenzirovanii ob"ektov patentnyh prav // Severo-Kavkazskij yuridicheskij vestnik. — 2018. — № 2. — S. 71–75.
16. Aziz S. F. Linking Intellectual Property Rights with Research and Development, Technology Transfer, and Foreign Investment: A Case Study of Egypt’s Pharmaceutical Industry // ILSA Journal of International & Comparative Law. — 2003. — Vol. 10. — № 1. — 22 p.
17. Shapiro R. J., Mathur A. How India Can Attract More Foreign Direct Investment, Create Jobs, and Increase GDP: The Benefits of Respecting the Intellectual Property Rights of Foreign Pharmaceutical Producers // Georgetown McDonough School of Business Research Paper № 2540591. — 2014. — 50 p.
Review
For citations:
Puchinina M.M. Conditions for Granting Compulsory License for Dependent Invention Use. Actual Problems of Russian Law. 2021;16(11):117-132. (In Russ.) https://doi.org/10.17803/1994-1471.2021.132.11.117-132